Interstitial Granulomatous Dermatitis as an Adverse Reaction to Vedolizumab.

Cutis

Ms. Beuerlein is from the Wake Forest School of Medicine, Winston-Salem, North Carolina. Drs. Martin and Strowd are from the Department of Dermatology, Wake Forest Baptist Health, Winston-Salem.

Published: March 2022

AI Article Synopsis

Article Abstract

A 61-year-old woman with a medical history of ulcerative colitis (UC) developed an erythematous, mildly pruritic, maculopapular rash that was histologically consistent with reactive granulomatous dermatitis (RGD) with interstitial granulomatous dermatitis (IGD)-type features 1 week after vedolizumab infusion. Awareness of this complication is key to enhanced recognition and appropriate management as use of this medication becomes more prevalent.

Download full-text PDF

Source
http://dx.doi.org/10.12788/cutis.0467DOI Listing

Publication Analysis

Top Keywords

granulomatous dermatitis
12
interstitial granulomatous
8
dermatitis adverse
4
adverse reaction
4
reaction vedolizumab
4
vedolizumab 61-year-old
4
61-year-old woman
4
woman medical
4
medical history
4
history ulcerative
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!